US PA Philadelphia Falk MJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|country=USA | |country=USA | ||
|weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ] | |weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ] | ||
|Contact=Falk | |Contact=Falk Marni J | ||
|MiPNetLab=Polyak | |MiPNetLab=Polyak Erzsebet | ||
|Status=O2k 2008- | |Status=O2k 2008- | ||
|info=[[MiPNet19.06 IOC91 |IOC91 Philadelphia]], [http://www.oroboros.at/?IOC47 IOC47] | |info=[[MiPNet19.06 IOC91 |IOC91 Philadelphia]], [http://www.oroboros.at/?IOC47 IOC47] | ||
Revision as of 15:27, 5 August 2014
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
